COVI-TRACK (Antibody Test for the Detection of Antibodies to SARS-CoV-2)

Sorrento is developing the COVI-TRACKTM  in vitro diagnostic test kit for the detection of IgG and IgM antibodies in blood samples from patients who may have been exposed to the SARS-CoV-2 virus.

The rapid antibody test kit is easy to use and allows for results to be available in about eight minutes. The test develops three clear lines to confirm the detection and differentiation of IgM and IgG antibodies associated with the SARS-CoV-2 virus.

Analytical validation was performed by testing sample cohorts from healthy donors and confirmed positive COVID-19 patient samples by RT-PCR testing, and the assay demonstrated a specificity greater than 97% and diagnostic sensitivity of greater than 94%. Upon issuance of an EUA, the COVI-TRACK test will be available for distribution to clinical testing sites nationwide.